Creative Planning
INBX icon

Creative Planning’s Inhibrx INBX Stock Holding History

Creative Planning’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$617K Sell
6,514
-104
-2% -$10.4K ﹤0.01% 3032
2026
Q1 		$445K Buy
6,618
+910
+16% +$67.5K ﹤0.01% 3114
2025
Q4 		$451K Buy
+5,708
New +$389K ﹤0.01% 2931
2025
Q1 		– Sell
-222
Closed -$3.42K – 3596
2024
Q4 		$3.42K Buy
+222
New +$3.38K ﹤0.01% 3430

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning's INBX Position: Q2 2026 in Review

Creative Planning reduced its Inhibrx (INBX) stake by 1.6% in Q2 2026, selling an estimated $10.4K and leaving 6,514 shares worth $617K. The position accounts for ﹤0.01% of the portfolio, ranked #3032.

Creative Planning first reported a position in INBX in Q4 2024 and has held it in 4 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Creative Planning held 6,514 shares of Inhibrx worth $617K as of Q2 2026.
  • Creative Planning sold 104 Inhibrx shares in Q2 2026, an estimated $10.4K.
  • Inhibrx made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3032 holding.
  • Creative Planning first reported a position in Inhibrx in Q4 2024 and has held it in 4 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.